EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Clinical and Economic Outcomes of Drug-Related Problems in Virtual vs. in-Person Transplant Pharmacotherapy Clinics: A Cross-sectional Study

Mahnaz Sadat Hosseini, Seyed Hossein Hajimiri, Simin Dashti, Mohsen Nasiri-Toosi, Marjan Moghadamnia, Monavar Talebian, Abbas Kebriae

Journal of Reports in Pharmaceutical Sciences · 04.11.2026 · 14 (1)

DOI: 10.5812/jrps-173261 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Reports in Pharmaceutical Sciences, online erschienen am 04.11.2026. Verfasst von Mahnaz Sadat Hosseini und 6 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pharmacist-led virtual transplant pharmacotherapy consultations are important for optimizing medication use and identifying drug-related problems (DRPs) that may contribute to preventable adverse drug events in solid organ transplant recipients. Evidence regarding the clinical and economic outcomes of virtual transplant pharmacotherapy clinics remains sparse, particularly in resource-limited settings.

Objectives

This study descriptively evaluated pharmacist-led virtual and in-person transplant pharmacotherapy clinics in separate real-world cohorts.

Methods

This cross-sectional study evaluated SOT candidates and recipients who attended a virtual clinic (October–December 2024) or an in-person clinic (September 2024–May 2025) at a tertiary transplant center in Iran. Pharmacists reconciled medications, resolved DRPs, monitored adherence, and reviewed vaccinations. ADE risk was assessed using a validated risk matrix, and a partial cost-benefit analysis was conducted from a limited societal perspective. Monetized benefits and intervention costs were summarized using benefit-to-cost ratios.

Results

A total of 232 patients (63.4% male; mean age, 50.3 ± 12.4 years [SD]) were evaluated. Pharmacists detected 1,607 DRPs and made 2,268 recommendations; the most frequent DRP was the need for preventive therapy. Using a risk-matrix approach, an expert panel estimated a total of 136.84 expected preventable adverse drug events across the two clinic models. These estimates were used for cost-avoidance modeling rather than direct observation of ADE occurrence. The virtual clinic generated direct cost savings of $1,882.93 and cost avoidance of $30,552.43, whereas the in-person clinic generated direct savings of $768.07 and cost avoidance of $75,666.94. The resulting BCRs were 11.12 for the virtual clinic and 12.31 for the in-person clinic, indicating that both clinic models were cost-beneficial under the study assumptions.

Conclusions

Pharmacist-led virtual and in-person transplant pharmacotherapy clinics were associated with improved vaccination coverage and provided preliminary evidence of potential clinical and economic benefits. These findings support further evaluation of virtual clinics as a feasible complement to in-person transplant pharmacotherapy services, particularly in low- and middle-income health care settings.

Zitieren

APA

Hosseini, M. S., Hajimiri, S. H., Dashti, S., Nasiri-Toosi, M., Moghadamnia, M., Talebian, M., & Kebriae, A. (2026). Clinical and Economic Outcomes of Drug-Related Problems in Virtual vs. in-Person Transplant Pharmacotherapy Clinics: A Cross-sectional Study. Journal of Reports in Pharmaceutical Sciences, 14(1). https://doi.org/10.5812/jrps-173261

Vancouver

Hosseini MS, Hajimiri SH, Dashti S, Nasiri-Toosi M, Moghadamnia M, Talebian M, et al. Clinical and Economic Outcomes of Drug-Related Problems in Virtual vs. in-Person Transplant Pharmacotherapy Clinics: A Cross-sectional Study. Journal of Reports in Pharmaceutical Sciences. 2026;14(1). doi:10.5812/jrps-173261

BibTeX
@article{Hosseini2026,
  author = {Hosseini, Mahnaz Sadat and Hajimiri, Seyed Hossein and Dashti, Simin and Nasiri-Toosi, Mohsen and Moghadamnia, Marjan and Talebian, Monavar and Kebriae, Abbas},
  title = {Clinical and Economic Outcomes of Drug-Related Problems in Virtual vs. in-Person Transplant Pharmacotherapy Clinics: A Cross-sectional Study},
  journal = {Journal of Reports in Pharmaceutical Sciences},
  year = {2026},
  volume = {14},
  number = {1},
  doi = {10.5812/jrps-173261}
}
Kostenlos starten →